nature.com
Synthetic lethal strategies for the development of cancer therapeutics - Nature Reviews Clinical Oncology
The experience with PARP inhibitors provides evidence of the clinical utility of synthetic lethality, whereby the simultaneous presence of two specific alterations is required for antitumour activity....